Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A contemporary update on glioblastoma: molecular biology, current management, and a vision towards bio-adaptable personalized care
Ahmed Habib, Matthew Pease, Chowdari V. Kodavali, et al.
Journal of Neuro-Oncology (2021) Vol. 151, Iss. 2, pp. 103-112
Closed Access | Times Cited: 17

Showing 17 citing articles:

Personalized Treatment of Glioblastoma: Current State and Future Perspective
Alen Rončević, Nenad Koruga, Anamarija Soldo Koruga, et al.
Biomedicines (2023) Vol. 11, Iss. 6, pp. 1579-1579
Open Access | Times Cited: 25
Glut-3 Gene Knockdown as a Potential Strategy to Overcome Glioblastoma Radioresistance
Gaia Pucci, Luigi Minafra, Valentina Bravatà, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 4, pp. 2079-2079
Open Access | Times Cited: 7
Engineered nanovesicles targeting SERPINE1 overcome temozolomide resistance in glioblastoma
Jianping Wen, Ding Wen Wu, Yi Le, et al.
Cellular Signalling (2025), pp. 111763-111763
Closed Access
Circumventing glioblastoma resistance to temozolomide through optimal drug combinations designed by systems pharmacology and machine learning
Sergio Corridore, Maïté Verreault, Hugo Martin, et al.
British Journal of Pharmacology (2025)
Open Access
Characteristics of long-term glioblastoma survivors diagnosed from 2010 to 2016 in the United States
Christine Ann Pittman Ballard, Yübo Wang, Carol Kruchko, et al.
Cancer Epidemiology (2025) Vol. 97, pp. 102810-102810
Closed Access
Effects of Dendrimer-microRNA Nanoformulations against Glioblastoma Stem Cells
Nadezhda Knauer, Mariya I. Meschaninova, Sajjad Muhammad, et al.
Pharmaceutics (2023) Vol. 15, Iss. 3, pp. 968-968
Open Access | Times Cited: 8
Novel Concepts of Glioblastoma Therapy Concerning Its Heterogeneity
Gábor Hutóczki, József Virga, Zsuzsanna Birkó, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 18, pp. 10005-10005
Open Access | Times Cited: 19
Nanotechnology-Based Combinatorial Anti-Glioblastoma Therapies: Moving from Terminal to Treatable
Amir Barzegar Behrooz, Zahra Talaie, Amir Syahir
Pharmaceutics (2022) Vol. 14, Iss. 8, pp. 1697-1697
Open Access | Times Cited: 12
Tuning a Bioengineered Hydrogel for Studying Astrocyte Reactivity in Glioblastoma
Thomas J. DePalma, Colin L. Hisey, Kennedy Hughes, et al.
Acta Biomaterialia (2024)
Closed Access | Times Cited: 2
An Overview of Nanotherapeutic Drug Delivery Options for the Management of Glioblastoma
William H. Pentz, Vincenzo J. Pizzuti, Matthew Halbert, et al.
Journal of Nanotheranostics (2023) Vol. 4, Iss. 3, pp. 323-345
Open Access | Times Cited: 5
Genomic Analysis of Glioblastoma Multiforme Reveals a Key Transcription Factor Signature Relevant to Prognosis and the Immune Processes
Zhen-Hang Li, Yanlei Guan, Guobin Zhang
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 8
CXCR2-Blocking Has Context-Sensitive Effects on Rat Glioblastoma Cell Line Outgrowth (S635) in an Organotypic Rat Brain Slice Culture Depending on Microglia-Depletion (PLX5622) and Dexamethasone Treatment
Johannes Falter, Annette Lohmeier, Petra Eberl, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 23, pp. 16803-16803
Open Access | Times Cited: 2
The Evolving Role of Induced Pluripotent Stem Cells and Cerebral Organoids in Treating and Modeling Neurosurgical Diseases
Nicolina Jovanovich, Ahmed Habib, Chowdari V. Kodavali, et al.
World Neurosurgery (2021) Vol. 155, pp. 171-179
Closed Access | Times Cited: 5
Circumventing glioblastoma resistance to temozolomide through optimal drug combinations designed by quantitative systems pharmacology and machine learning
Sergio Corridore, Maïté Verreault, Hugo Martin, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Tuning a Bioengineered Hydrogel for Studying Astrocyte Reactivity in Glioblastoma
Thomas J. DePalma, Colin L. Hisey, Kennedy Hughes, et al.
(2024)
Closed Access
Expression Profiles of HOXC6 Predict the Survival of Glioblastoma Patients and Correlate with Cell Cycle
Zhen-Hang Li, Yue Ma, Yan Zhou, et al.
Journal of Oncology (2022) Vol. 2022, pp. 1-17
Open Access | Times Cited: 1
A Pilot Clinical Study of CUSP9v3: Nine Repurposed Drugs Combined With Temozolomide for the Treatment of Recurrent Glioblastoma
Marc‐Eric Halatsch, Richard E. Kast, Georg Karpel‐Massler, et al.
Research Square (Research Square) (2021)
Open Access
Page 1

Scroll to top